| 000 | 00944cam a22002531 4500 | ||
|---|---|---|---|
| 001 | 6112557 | ||
| 003 | BD-DhUL | ||
| 005 | 20150121101725.0 | ||
| 008 | 720428s1964 dcua b 100 0 eng | ||
| 010 | _a 64022278 | ||
| 035 | _a(OCoLC)296290 | ||
| 040 | _cBD-DhUL | ||
| 042 | _apremarc | ||
| 050 | 0 | 0 |
_aQD1 _b.A355 no. 45 |
| 082 |
_a615.19 _bMOL |
||
| 245 | 0 | 0 |
_aMolecular modification in drug design; _ba symposium sponsored by the Division of Medicinal Chemistry at the 145th meeting of the American Chemical Society, New York, N.Y., Sept. 9-10, 1963. _cFred W. Schueler, symposium chairman. |
| 260 |
_aWashington, _bAmerican Chemical Society, _c1964. |
||
| 300 |
_avii, 228 p. _billus. _c24 cm. |
||
| 440 | 0 |
_aAdvances in chemistry series, _v45 |
|
| 504 | _aIncludes bibliographies. | ||
| 650 | 0 |
_aPharmaceutical chemistry _vCongresses. |
|
| 710 | 2 |
_aAmerican Chemical Society. _bDivision of Medicinal Chemistry. |
|
| 942 |
_2ddc _cBK |
||
| 999 |
_c34254 _d34254 |
||